Cancer death rates in the UK have reached a historic low, as reported by Cancer Research UK. The charity’s analysis revealed a significant 11% decrease in death rates over the past decade. Currently, it is estimated that 247 out of every 100,000 individuals in the UK succumb to cancer each year, marking a notable 29% decline from the peak rate of 355 per 100,000 in 1989. The data also highlights positive trends in specific cancer types, with ovarian cancer rates dropping by 19%, stomach cancer by 34%, and lung cancer by 22% between the periods of 2012-2014 and 2022-2024.
Furthermore, there have been improvements in the mortality rates of various cancers, such as a 6% decrease in bowel cancer, 14% in breast cancer, 11% in cervical cancer, 9% in leukaemia, and 12% in oesophageal cancer. However, some cancers have seen an increase in death rates, including gallbladder cancer (up by 29%), eye cancer (up by 26%), liver cancer (up by 14%), and kidney cancer (up by 5%). Nonetheless, thyroid cancer, pancreatic cancer, and melanoma have remained stable in terms of mortality rates.
One of the most significant success stories is the 75% reduction in death rates for cervical cancer since the 1970s, attributed to the NHS cervical screening program. Additionally, the decline in cervical cancer cases has been further aided by the human papillomavirus (HPV) vaccine, which has been administered to schoolchildren since 2008, with over 6.5 million individuals in the UK receiving the vaccine.
Dr. Sam Godfrey, the science engagement lead at Cancer Research UK, emphasized the importance of continuous scientific advancements in cancer prevention and treatment. He credited these breakthroughs for enabling thousands of individuals to create lasting memories, achieve milestones, and spend quality time with their loved ones. He also stressed the need for ongoing government support to streamline the process of setting up clinical trials and provide healthcare professionals with the necessary resources to conduct life-saving research.
The charity highlighted that death rates for prostate cancer have decreased by 11% in the past decade due to improved treatment options. Additionally, initiatives such as smoking bans and the implementation of nationwide screening programs for breast, bowel, and cervical cancers have played a crucial role in driving down mortality rates. However, despite these positive developments, the overall number of cancer-related deaths continues to rise due to a growing and aging population.
In conclusion, the advancements in cancer research and prevention efforts in the UK have led to significant improvements in mortality rates for various cancer types. Continued support for research initiatives and public health programs is essential to further reduce the impact of cancer on individuals and communities.
SOURCE